RCA Telegram News California - News from San Francisco, California, the USA and the world, around the clock every day

Rockhaven Reports Multiple High-Grade Vein Exposures at its Klaza Gold-Silver Project, Yukon
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue

Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure due to microvillus inclusion disease (MVID), reducing the volume of the total parenteral support (PS) necessary for them to survive, though with associated toxicity; Groundbreaking PS reduction of up to 37%; No approved treatments exist for MVIDCompany completed meeting with FDA October 2, 2025 for advice on possible expedited approval pathway to advance its ongoing placebo-controlled trial of crofelemer for potential approval for treatment of MVIDREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q3 2025 financials and company updates; Click here to register

November 17, 2025

RECENT NEWS

XCF Global and BGN Developing Global Distribution and Logistics Partnership
XCF Global and BGN Developing Global Distribution and Logistics Partnership

Strategic partnership between XCF Global and BGN to jointly develop global distribution and logistics infrastructure for SAF and other renewable fuelsSeeks to expand XCF's international reach into key markets including Europe and the Middle East through production, offtake, and co-branded distribution agreementsAdvances global renewable fuel supply chains to meet rapidly rising demand for SAF

November 17, 2025

Atlas Salt to Begin Trading on OTCQX Under the Symbol "SALQF"
Atlas Salt to Begin Trading on OTCQX Under the Symbol "SALQF"

ST. GEORGE'S, NEWFOUNDLAND AND LABRADOR / ACCESS Newswire / November 17, 2025 / Atlas Salt Inc. ("Atlas Salt" or the "Company") (TSXV:SALT)(OTCQX:SALQF) announces that, effective today, its shares will begin trading on OTCQX under the symbol "SALQF". Its shares had previously traded on the OTCQB Venture Market under the symbol "REMRF".

November 17, 2025

Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Medicus Pharma Ltd. Announces Filing of FDA Commissioner's National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health impact, unmet medical need, access, affordability, domestic manufacturing and rare-disease alignment.

November 17, 2025

RECENT NEWS

Earthwise Minerals Samples up to 13.4 g/t Gold, 27.2 g/t Silver, and 2.7% Lead During Summer Field Program
Earthwise Minerals Samples up to 13.4 g/t Gold, 27.2 g/t Silver, and 2.7% Lead During Summer Field Program

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Earthwise Minerals Corp. (CSE:WISE)(FSE:966) ("Earthwise" or the "Company") is pleased to announce that it has received results from 2025 fieldwork with samples grading up to 13.4 g/t Au, 27.2 g/t Ag, > 10,000 ppm As, and 2.7% Pb. Earthwise holds the exclusive option to acquire up to an 80% interest in the Iron Range Project from Eagle Plains Resources Ltd. (TSX-V:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains").

November 17, 2025

RECENT NEWS

Camino Completes C$5.6 Million Investment with Strategic Investors
Camino Completes C$5.6 Million Investment with Strategic Investors

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino.

November 17, 2025